Atlas Trials

Epidermal Growth Factor Receptor Mutations

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Epidermal Growth Factor Receptor Mutations

RecordFirmDate
A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations (NCT02113813)Astellas Pharma Global Development, Inc.2014-04-09

Track Epidermal Growth Factor Receptor Mutations automatically

Every clearance here is in the API, with alerts when new ones post.